Navigation Links
European Society of Human Reproduction & Embryology 24th annual meeting
Date:4/14/2008

Reproductive medicine is one of the most exciting scientific and clinical areas. Every month brings announcements of research developments, medical firsts, new rulings by regulatory bodies, or ethical controversies often sparking heated debate among practitioners in the field themselves, as well as ethicists, legislators, the media and the public.

ESHREs annual meeting is the forum where more than 5,000 of the worlds leading experts in reproductive medicine gather to give the first public presentation of their latest research findings and to discuss issues that are presenting law-makers and ethicists with some of the most challenging problems and difficult decisions currently facing society.

We welcome the media to the meeting. All sessions are open to journalists and registration is free to bona fide journalists on presentation of official press credentials. A media centre with computers, fax, printing, photocopying and free local and international telephone facilities and internet connections will be available.

English and Spanish-speaking press office staff will be on hand to assist you. But please note that the official conference language is English. There are no simultaneous translations.

To register: download the form at http://www.eshre.com/emc.asp?pageId=294 and fax, with a photocopy of your press credentials, to:

Sarah de Potter, ESHRE communications manager
Fax: +32/2/269 56 00
Tel: +32/473/ 35 33 81
Email: sarah@eshre.com

For more information contact Sarah de Potter or Mary Rice (mary@mrcommunication.org; tel: +33 (0)3 21825444) or visit the ESHRE website: http://www.eshre.com

Registration in advance is recommended, but you may register on site providing that you produce press credential
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Medical Services International Inc. Completes Testing for European Union (EU) Application
4. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. Launch of second European Cancer Research Funding survey
7. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
8. Pharsight to Host European Software Conference
9. OmniGuide Begins European Commercialization
10. Paving the way for future pan-European clinical trials
11. US, European cancer educators gather in Alabama for meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...that many were convicted since 1990’s, and in 2004...victed //but the Journal of the Royal Society of M...ngeance and retribution, Birmingham City Hospital ...d been charged with manslaughter since 1795. Bec...
...g thousands of rainbow trout.Due to an outbreak, f...ery first case of viral haemorrhagic septicaemia (...ficial across the catchment area of the river Ouse...lso experienced this before on farmed turbot in 19...
...ed that the world would require US $ 22 billion to...er, it is not sure from where the countries will g...dress the issue of AIDS, UN members appreciated th... companies producing generic antiretroviral drugs ...
...was found that Washington employers were paying mo... hospitals and doctors serving Medicare and Medica...tive officer of Mountlake Terrace-based Premera, s... cost-shifting. Others call it a hidden tax’. Thus...
Other Medicine News:
(Date:8/27/2008)...rstCall/ --, - Oralair(R) Grasses 300IR Highly Po... Conducted in an Allergen Challenge Chamber, Stal...s of a new study,conducted in an Allergen Challeng... included 86 adult patients exposed to,grass polle...week, 1 month,2 and 4 months without a titration ...
(Date:8/26/2008)...k SYNTAX clinical trial, NATICK, Mass., Aug. 26 /...tion (NYSE: BSX ) today announced the schedule of...s at the European Society of Cardiology,Congress 2...unich, Germany., The Company plans to announce 12...percutaneous coronary intervention (PCI) using the...
(Date:8/26/2008)...-- Healthpoint today announced,that it has initiat...of a,widely prescribed enzymatic debriding agent o...e pilot study was prompted, in part, by clinical r...ars and beneficial healing,properties associated w...the findings from the peer-reviewed literature, as...
(Date:8/26/2008)...Corporation today announced the,publication of the...g,OMS103HP in arthroscopic anterior cruciate ligam...nvestigational drug product that is added to,arthr...rove postoperative,knee function and motion, reduc... return to work. The article titled "Novel Drug Pr...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Touch Bionics acquires LIVINGSKIN 5421 1Touch Bionics acquires LIVINGSKIN 5421 2Touch Bionics acquires LIVINGSKIN 5421 3Going barefoot 3F Beware 21 19426 1Going barefoot 3F Beware 21 19426 2Eat Your Vegetables That Means You Parents 21 19423 1Eat Your Vegetables That Means You Parents 21 19423 2Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 19420 1Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 19420 2Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 19420 3
...VERTON, R.I., June 18, 2007 /PRNewswire/ -- VeroSc...lthcare product development,company, announced tod...ed as a poster presentation at the 67th Scientific...Chicago, Ill. The abstract,entitled, "Effects of ... Bromocriptine Mesylate) Administration of Safety,...
...TON, Mass.--(BUSINESS WIRE)--Jun 18, 2007 - Novelo...tical company,focused on the development of therap...ced encouraging results in an ongoing,Dana-Farber/...-002,in combination with carboplatin in platinum-r...ents were evaluable for best,overall tumor respons...
Other Medicine Technology:VeroScience Late-Breaking Abstract on Cycloset (A Quick Release,Formulation of Bromocriptine Mesylate) Accepted for Poster,Presentation at American Diabetes Association 67th Scientific,Sessions 2Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 2Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 3
The PachPen uses state-of-the-art waveform analysis and a probe that samples at a 65MHz rate to obtain precise readings. The PachPen stores and averages nine measurements and calculates IOP correctio
...ailable as both regular and filter tips. Sterilize...re efficient sterilization and are delivered with ...e of irradiation. Sterilized Diamond Tips are read...k Diamond Tips are wrapped in medical device quali...
300 L, Bulk Recommended for 250 and 300 L pipettes.
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio
Medicine Products: